Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

113 ARTÍCULOS , VIENDO DEL 46 AL 60

One-year Outcome of Shanghai Mild Cognitive Impairment Cohort Study

Zhou B, Zhao Q, Kojima S, Ding D, Higashide S, Nagai Y, Guo Q, Kagimura T, Fukushima M, Hong Z.

Curr Alzheimer Res. 2019;16(2):156-165. doi: 10.2174/1567205016666181128151144.

Getting to the Heart of Alzheimer Disease

Tublin JM, Adelstein JM, Del Monte F, Combs CK, Wold LE.

Circ Res. 2019 Jan 4;124(1):142-149. doi: 10.1161/CIRCRESAHA.118.313563.

Neuroinflammation in mild cognitive impairment and Alzheimer's disease: A meta-analysis

Bradburn S, Murgatroyd C, Ray N.

Ageing Res Rev. 2019 Mar;50:1-8. doi: 10.1016/j.arr.2019.01.002. Epub 2019 Jan 2.

Prevalence and risk of progression of preclinical Alzheimer's disease stages: a systematic review and meta-analysis

Parnetti L, Chipi E, Salvadori N, D'Andrea K, Eusebi P.

Alzheimers Res Ther. 2019 Jan 15;11(1):7. doi: 10.1186/s13195-018-0459-7.

The current understanding of overlap between characteristics of HIV-associated neurocognitive disorders and Alzheimer's disease

Rubin LH, Sundermann EE, Moore DJ.

J Neurovirol. 2019 Oct;25(5):661-672. doi: 10.1007/s13365-018-0702-9. Epub 2019 Jan 22.

Potentially modifiable factors associated with agitation and aggression in Alzheimer's disease: results of the ICTUS study

de Mauleon A, Soto M, Ousset PJ, Nourhashemi F, Lepage B, Vellas B.

Int Psychogeriatr. 2019 Oct;31(10):1509-1516. doi: 10.1017/S1041610218001990.

Auditory Brainstem Dysfunction, Non-Invasive Biomarkers for Early Diagnosis and Monitoring of Alzheimer's Disease in Young Urban Residents Exposed to Air Pollution

Mansour Y, Blackburn K, González-González LO, Calderón-Garcidueñas L, Kulesza RJ.

J Alzheimers Dis. 2019;67(4):1147-1155. doi: 10.3233/JAD-181186.

The Potential of 'Omics to Link Lipid Metabolism and Genetic and Comorbidity Risk Factors of Alzheimer's Disease in African Americans

Stepler KE, Robinson RAS.

Adv Exp Med Biol. 2019;1118:1-28. doi: 10.1007/978-3-030-05542-4_1.

Is Alzheimer's Disease Risk Modifiable?

Serrano-Pozo A, Growdon JH.

J Alzheimers Dis. 2019;67(3):795-819. doi: 10.3233/JAD181028.

Brief cognitive screening instruments for early detection of Alzheimer's disease: a systematic review

De Roeck EE, De Deyn PP, Dierckx E, Engelborghs S.

Alzheimers Res Ther. 2019 Feb 28;11(1):21. doi: 10.1186/s13195-019-0474-3.

Focus on the Correlations between Alzheimer's Disease and Type 2 Diabetes

Fiore V, De Rosa A, Falasca P, Marci M, Guastamacchia E, Licchelli B, Giagulli VA, De Pergola G, Poggi A, Triggiani V.

Endocr Metab Immune Disord Drug Targets. 2019;19(5):571-579. doi: 10.2174/1871530319666190311141855.

Polygenic risk and hazard scores for Alzheimer's disease prediction

Leonenko G, Sims R, Shoai M, Frizzati A, Bossù P, Spalletta G, Fox NC, Williams J; GERAD consortium; Hardy J, Escott-Price V.

Ann Clin Transl Neurol. 2019 Feb 18;6(3):456-465. doi: 10.1002/acn3.716. eCollection 2019 Mar.

Metabolic Syndrome, Mild Cognitive Impairment, and Dementia: A Meta-Analysis of Longitudinal Studies

Atti AR, Valente S, Iodice A, Caramella I, Ferrari B, Albert U, Mandelli L, De Ronchi D.

Am J Geriatr Psychiatry. 2019 Jun;27(6):625-637. doi: 10.1016/j.jagp.2019.01.214. Epub 2019 Feb 15.

An urgent need to assess safe levels of inorganic copper in nutritional supplements/parenteral nutrition for subset of Alzheimer's disease patients

Kumar A, Sharma P, Prasad R, Pal A.

Neurotoxicology. 2019 Jul;73:168-174. doi: 10.1016/j.neuro.2019.04.001. Epub 2019 Apr 4.

APOE ɛ4 and REM Sleep Behavior Disorder as Risk Factors for Sundown Syndrome in Alzheimer's Disease

Pyun JM, Kang MJ, Yun Y, Park YH, Kim S.

J Alzheimers Dis. 2019;69(2):521-528. doi: 10.3233/JAD-190032.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias